Trials / Recruiting
RecruitingNCT05974488
The Efficacy of Distal Pharyngeal Airway for Oxygenation During TEE
The Efficacy of Distal Pharyngeal Airway in Enhancing Oxygenation During Transesophageal Echocardiography (TEE) in Patients Sedated With Propofol
- Status
- Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 50 (estimated)
- Sponsor
- University of Miami · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to investigate the effect of using the McMurray Enhanced Airway (MEA) which is a flexible extended-length distal pharyngeal airway on improving oxygen delivery compared to standard nasal cannula.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | McMurray Enhanced Airway | The MEA is non-sterile. It can be used in inpatient or outpatient surgery, in hospital or clinic settings, or in an emergency setting. The MEA has five parts: an optional 15 mm connector, flange (color-coded for size), elongated cushioned bite block, flexible cannula, and distal tip, and a channel to allow for passage of air and a suction catheter. The MEA is designed to open and maintain a patient's upper airway. Oxygen will be delivered through the breathing circuit with the following parameters: 40% oxygen at 6 liters/min flow throughout the procedure time. The MEA will be placed in the participant's oropharyngeal airway one time during an in-person visit. |
| DEVICE | Nasal Cannula | Participants in this group will use the nasal cannula to deliver oxygen as per standard of care one time during the in-person visit. |
Timeline
- Start date
- 2023-11-30
- Primary completion
- 2026-10-01
- Completion
- 2026-10-01
- First posted
- 2023-08-03
- Last updated
- 2025-10-06
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT05974488. Inclusion in this directory is not an endorsement.